Summary Of Loading Off Bottom - As At Close May 28.

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
107
Summary Of Loading Off Bottom - As At Close May 28.

Bought at 1.4001 > 1.6000 [.0008]

Jan 15: 1,750

Total: 1,750

Bought at 1.2001 > 1.4000 [.0007]

Jan 15: 1,247

Total: 1,247

Bought at 1.0001 > 1.2000 [.0006]

Jan 15: 3,179

Total: 3,179

Bought at .8001 > 1.000 [.0005]

Jan 15: 2,484
Jan 16: 1,200
Jan 17: 1,330
Jan 18: 50

Total: 5,064

Bought at .6001 > .8000 [.0004]

Jan 15: 8,027
Jan 16: 2,411
Jan 17: 13,000
Jan 18: 235
Jan 22: 1,000

Total: 24,673

Bought at .4000 > .6000 [.0003]

Jan 18: 88,566
Jan 22: 16,500
Jan 23: 1,330
Jan 24: 300
Jan 25: 2,040
Jan 29: 6,319
Jan 30: 14,895 [all above .4200 - most around .4400]
Jan 31: 5,877
Feb 1: 8,100
Feb 4: 626
Feb 6: 230
Feb 7: 18,368
Feb 15: 674
Feb 19: 1,926 [all at .4200 / .4300]
Feb 20: 4,127 [all at .4425 > .4500]
Feb 22: 3,370 [.4500 / .4600 / .4999 / 2000 at .5267]
Feb 25: 25,902 [16,859 .4600 > .5000 / 5,660 .5200 > .5985]
Feb 26: 21,078 [18,778 .4750 > .4975 / 2,300 .5050 > .5500]
Feb 27: 10,350 [6,200 .4500 > .4780 / 1,250 .5100 > 5775]
Feb 28: 18,050 [11,500 .4600 > .4999 / 950 .5000 > .5999]
Mar 1: 6,981 [all .4060 / .4100 / .4600]
Mar 4: 200 [all .4900 / .5100]
Mar 5: 80 [all .5100]
Mar 6: 10,522 [7,800 - 73% .5100]
Mar 7: 200 [50% .4700 / 50% .5100]
Mar 8: 23,820 [19,900 .4450 > .4700 / 3,920 .5100]
Mar 11: 3,818 [.4000 / .4500 / .5000]
Mar 12: 7,390 [1,800 .4500 / 5,410 .5000/.5100]
Mar 13: 78,449 [0 < .4500 / 46,898 .4900 > .5800 / 10,300 .5500 > .5800]
Mar 14: 2,420 [.4950 / .5100 / .5200]
Mar 15: 11,638 [.4900 / .5399 / .5400]
Mar 18: 2,848 [1,000 .5000 / 1,000 .5100 / 650 .5300]
Mar 19: 1,155 [.5205/.5524]
Mar 20: 902 [.5350/.5400]
Mar 21: 6,200 [.5400/.5790]
Mar 22: 14,918 [5,580 .5100 > .5699]
Mar 25: 9,645 [.5100 > .5979 / 8,074 .5499 / .5500]
Mar 26: 6,975 [4,000 .4850 > .4979 / 2,825 .5017 > .5970]
Mar 27: 2,959 [1,000 .5500 / 1,303 .5950]
Mar 28: 10,384 [3,850 .5500 > .5620 / 4,384 .5900 > .5950]
Mar 29: 4,788 [4,200 .5600 > .5700]
Apr 1: 20,085 [1,169 .5474 > .5789 / 5,250 .5800 / 10,200 .5900 > .5999]
Apr 2: 5,744 [2,150 .5200 > .5499 / 2,698 .5500 > .5900]
Apr 3: 20,479 [5,045 .5300 > .5500 / 7,533 .5600 > .5790 / 5,499 .5999]
Apr 4: 15,848 [7,933 .5000 / 4,915 .5100 > .5400 / 3000 .5600]
Apr 5: 1,799 [all .5000 > .5290]
Apr 8: 6,740 [ all .5000 > .5700]
Apr 9: 1,712 [.5000 / .5400 / 1,000 .5700]
Apr 10: 20,802 [12,851, .5000 / 7,900 .51525 / .5250 / .5300]
Apr 11: 3,953 [all .5250]
Apr 12: 5,255 [1200 .5200 - remainder of ask retreated to .5850]
Apr 15: 5,296 [3,860 .5200]
Apr 16: 4,526 [3,700 .5100/.5250]
Apr 17: 15,970 [ 1,734 .5000 / 2,000 .5100 / 8,070 .5200 > .5400]
Apr 18: 2,400 [400 .5400/.5500 / 1,000 .5850]
Apr 22: 1,815 [1,010 .5300]
Apr 23: 5,711 [4,071 .4750 / 1,640 .5000 > .5300]
Apr 24: 3,678 [3,025 .4800 > .5000 hidden bid / 600 .5150 > .5400]
Apr 25: 875 [.4800 > .5100]
Apr 26: 8,333 [8,265 .5100]
Apr 29: 14,119 [.4500 hidden bid > .5700]
Apr 30: 3,080 [.4500 hidden bid > .5100]
May 1: 308 [.5100 > .5148]
May 2: 1,704 [hidden bid .4500 > .5350]
May 3: 323 [hidden bid .4500 > .5300]
May 6: 675 [hidden bid .4500]
May 7: 2,082 [hidden bid .4500 / 100 .5100 / 1,772 .5288 > .5300]
May 8: 2,036 [hidden bid .4500 / 1,981 .5100 > .5250]
May 9: 625 [hidden bid .4500 / 250 .5139 > .5200]
May 10: 14,022 [visible bid .4500 then .4600 > .5200]
May 13: 968 [hidden bid .4500 / .5100 > .5200]
May 14: 3,737 [hidden bid .4500 / 2,119 .5100 > .5200]
May 15: 1,845 [hidden bid .5000 / .5100]
May 16: 3,984 [hidden bid .5000 / .5150]
May 17: 250 [hidden bid .5000]
May 20: 924 [hidden bid .4550 / 823 .5100
May 22: 41 [hidden bid .4550]
May 23: 279 [hidden bid .4550]
May 24: 4,312 [hidden bid .4550 / 555 .5100]
May 28: 700 [hidden bid .4550 / 100 .5100]

Total: 623,032

Bought at .2310 > .3999:

Jan 15: 10,418 [all at .0380 - .0002 equivalent]
Jan 18: 22,269
Jan 23: 16,052 [mostly .0370/.0380/.3999]
Jan 24: 18,089 [mostly .0380/.0399]
Jan 25: 17,456 [mostly .0370/.0380]
Jan 28: 23,054 [mostly .0360/.0370/.0390]
Jan 29: 4,189 [mostly at .3900]
Jan 31: 3,001 [all around .3700]
Feb 1: 230 [at .0380]
Feb 4: 4,090 [all at .3800/.3825/.3900]
Feb 5: 6,334 [all at .3800/.3801/.3825]
Feb 6: 222 [all at .3800/.3801/.3813]
Feb 7: 3,144 [all at .3800/.3850]
Feb 8: 71,730 [mostly at .3400/.3800]
Feb 11: 19,719 [ask was .3300/.3400]
Feb 12: 763 [paint downs under ask .3300]
Feb 13: 13,675 [mostly at .3300 >.3425 - then none available < .4000]
Feb 14: 1,146 [all at .3350 > .4000 - then none available < .4200]
Feb 15: 6,608 [almost all at .3900 - then none available <.4300]
Feb 19: 7,356 [all at .3500 or 3837/.3975]
Feb 20: 1,200 [only 200/250/500 at .3025 > .3200]
Feb 21: 990 [only 830/55/105 at .3025 > .3100]
Feb 22: 4,567 [1 at .3100 open p/d - then .3250/.3420/.3480/.3500/.3550]
Mar 1: 5,500 [all .3900 / .3905]
Mar 4: 277 [all .3900]
Mar 5: 186 [all .3900]
Mar 6: 113 [.3900]
Mar 11: 1,125 [paints below extant .3900 bid]
Mar 12: 3,128 [paints below extant .3900 bid]

Total: 239,237

Assume following worst case prior from loading on January 14:

Bought at 1.000 [.0005]: 10,000 [20M] [estimate]

Bought at .8000 [.0004]: 23,000 [46M] [estimate]

Bought at .6000 [.0003]: 50,000 [100M] [estimate]

Bought at .4000 [.0002] 200,000 [400M] [estimate]

Total: 283,000 [566M] [precise]










Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading

Top 5 Most Recently Viewed Articles

BioVaxys Unveils Private Placement to Boost Growth Initiatives

Updated Category News Views 83

BioVaxys Technology Corp. Announces Private Placement Offering BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) is thrilled to share its plans for a strategic move that aims to elevate its operational capabilities. The company intends to initiate a non-brokered private placement offering, introducing up to 14,285,715 units at a price of CAD$0.07 each. This initiative is...

Continue Reading
Cardiff Oncology Secures $40 Million Through Oversubscribed Offering

Updated Category News Views 104

Cardiff Oncology Completes Significant Stock Offering Cardiff Oncology, Inc. (Nasdaq: CRDF) has recently made headlines with its successful pricing of an underwritten offering, targeting a remarkable $40 million. This offering consists of 15,384,619 shares of its common stock, priced at $2.60 per share, with all shares being offered by the Company itself. The...

Continue Reading
Sungrow and Globeleq Partner for Major Battery Storage Project

Updated Category News Views 301

Sungrow and Globeleq Join Forces on Groundbreaking Energy Project Sungrow, a prominent name in the renewable energy sector, and Globeleq, a trusted independent power producer, have made a significant commitment by signing a term sheet. This partnership focuses on the supply and long-term service for the ambitious 153MW / 612MWh Red Sands Battery Energy Storage System...

Continue Reading
Helios Technologies Unveils the Advanced S35 Display System

Updated Category News Views 442

Helios Technologies Launches the Versatile S35 Display Helios Technologies, Inc. (NYSE: HLIO), known for its expertise in highly engineered motion control and electronic controls technology, has recently introduced the S35 display. This new addition showcases a unique blend of advanced technology, rugged durability, and user-friendliness, making it an exceptional...

Continue Reading
Ameriprise Financial Soars to New Heights: Stock Insights

Updated Category News Views 47

Ameriprise Financial Achieves All-Time High Ameriprise Financial Inc (NYSE: AMP) has recently marked an extraordinary achievement with its stock price reaching an all-time high of $524.01. This significant increase not only highlights the company’s performance but also reflects a robust surge in investor confidence, demonstrated by a remarkable 65.08% increase over the...

Continue Reading